Calliditas Therapeutics AB (publ)
CALT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$466 | -$422 | -$524 | -$380 |
| Dep. & Amort. | $17 | $13 | $34 | $3 |
| Deferred Tax | $0 | $0 | -$66 | $8 |
| Stock-Based Comp. | $53 | $36 | $22 | $6 |
| Change in WC | -$80 | $88 | $5 | $54 |
| Other Non-Cash | $208 | -$27 | $67 | -$0 |
| Operating Cash Flow | -$435 | -$311 | -$462 | -$309 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$3 | -$23 | $0 |
| Net Acquisitions | $0 | $0 | -$47 | -$173 |
| Inv. Purchases | -$2 | -$3 | -$2 | -$0 |
| Inv. Sales/Matur. | $1 | $0 | $71 | $0 |
| Other Inv. Act. | $0 | $0 | -$24 | -$173 |
| Investing Cash Flow | -$14 | -$5 | -$24 | -$173 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $226 | $482 | $194 | -$4 |
| Stock Issued | $0 | $0 | $324 | $891 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$27 | $94 | -$83 | -$119 |
| Financing Cash Flow | $200 | $576 | $435 | $769 |
| Forex Effect | -$27 | $34 | $10 | -$44 |
| Net Chg. in Cash | -$275 | $294 | -$41 | $243 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,249 | $956 | $996 | $754 |
| End Cash | $974 | $1,249 | $956 | $996 |
| Free Cash Flow | -$447 | -$314 | -$484 | -$309 |